赛诺菲的喜保宁购买途径和价格

The patent of Lundbeck's epilepsy treatment drug Sabil (vigabatrin, CAS registration number: 68506-86-5; translation: Ning/vigabatrin 500 mg tablet) expired, and the U.S. FDA approved the first generic version of the drug (generic name drug) on January 16, 2019.

This time, Teva Pharmaceuticals USA was approved to produce and sell vigabatrin 500 mg tablets for use in patients 10 years of age and older as an add-on treatment for the treatment of refractory complex partial epilepsy (also known as focal seizures).

Common toxic and side effects of vigabatrin tablets include dizziness, fatigue, drowsiness, nystagmus (nystagmus), tremors, blurred vision, memory impairment, weight gain, joint pain, upper respiratory tract infection, aggression, diplopia, abnormal movement coordination, etc. Serious side effects include permanent blindness and suicidal tendencies and behaviors. There is a warning text in a black box in the package insert of this medicine to remind doctors and patients that this medicine may cause permanent blindness.

Where to buy Sanofi and its price? Currently, more patients are keen on Sanofi's Vigabatrin on the market. Sanofi (NYSE: SNY) was founded in 1973. Its predecessor was Sanofi-Aventis. It was changed to its current name: Sanofi in May 2011. It is headquartered in Paris, France, and has 113,496 full-time employees in more than 100 countries around the world. It is the world's leading diversified pharmaceutical and health company with diversified products, including drugs, vaccines and innovative treatment solutions. According to Medical Companion Travel, the specification of Sanofi Vigabatrin is 500mg*100 capsules/box, and the price is equivalent to RMB 1,450. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Vigabatrin, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.